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In view of the high incidence and mortality of coronary artery disease (CAD) in patients with kidney
transplantation, a systematic cardiac evaluation was prospectively performed in 103 uraemic patients eligible
for transplantation. After clinical examination, 28 patients with symptoms of CAD or diabetes mellitus were
referred directly for coronary angiography, whereas the remaining 75 patients had rest and exercise radio-
nuclide angiocardiography for evaluation of possible asymptomatic CAD. Among them, left ventricular
ejection fraction was below 40% at rest or fell during exercise by at least 5 EF% in 12 patients; coronary
angiography in nine showed CAD in four and hypertensive heart disease in five. In the remaining 63 (of
75) patients without severe resting left ventricular dysfunction or exercise ischaemia, the follow-up of
28 ±7 months revealed no clinical manifestation of CAD. Overall incidence of CAD in symptomatic and
asymptomatic patients during a follow-up of 27 months after cardiac evaluation was 20 and 25% in non-
diabetic and diabetic candidates for kidney transplantation, respectively (P = n.s.). Thus, clinical examination
combined with exercise radionuclide angiocardiography in patients without signs or symptoms of heart disease
had a high predictive accuracy for presence or absence of late manifestations of CAD. Exercise radionuclide
angiocardiography is therefore a useful method for screening kidney transplantation candidates for
asymptomatic CAD.
Introduction disease and poor prognosis could be identified who
Cardiovascular disease is common in patients with m i 8 h t ** denied kidney transplantation based on
chronic renal failure""31. Of 59 patients who died objective cardiac investigations,
after kidney transplantation in Basel between 1967 B a s e d o n s u c h considerations, a protocol for
and 1985, and in whom autopsy was performed, 21 systematic cardiac evaluation was set up and
(36%) showed significant coronary artery disease followed prospectively between 1984 and 1987.
and in nine (15%) acute myocardial infarction Symptomatic cardiac patients underwent coronary
was the cause of death. The EDTA Registry has angiography; patients without cardiac symptoms
reported a similar proportion of fatal coronary were screened by exercise radionuclide angiocardio-
events after kidney transplantation'41. graphy (RNA) which was followed by left heart
Therefore, it is important to identify patients catheterization if the examination suggested CAD.
with significant coronary artery disease (CAD) Patients with renal failure due to juvemle diabetes
before kidney transplantation. This is routine prac- m e l l i t u s underwent coronary angiography irrespec-
tice in patients with symptoms of cardiac disease, t l v e o f cardiac symptoms. The following report
but non-invasive examination should allow detec- Presents the results of a systematic assessment and
tion of clinically occult CAD at an early state and follow-up of this strategy in order to define a 'best1
thus institution of vigorous medical and/or surgical f u t u r e o ^ i a c evaluation of patients with chronic
therapy. In addition, patients with severe heart renal f a i l u r e ^fore kidney transplantation.
Submitted for publication on 1 June 1989, and in revised form 16
November 1989. Patients
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CH-4031 Basel/Switzerland. patients were evaluated as candidates for kidney
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Table I Baseline characteristics of 103 candidates for kidney transplantation
Number of patients (n)
Women (%)
Age (years)
Cause of renal failure (%):
toxic interstitial nephritis
glomenilonephritis
polycystic kidney disease
pyelonephritis, postrenaJ obstruction
nephrosclerosis
tuberculosis
diabetes mellitus
cause unkown
Arterial hypertension (%)
Patients on haemodialysis (%)
duration (months)
Group 1
75
63
51-6±9 3
36
26
14
12
1
0
0
10
66
96
ll-9±12-8
Group 2
19
47
56-3 ±5-4
42
5
11
5
11
5
0
21
46
95
17-3± 18-2
Group 3
9
87
46-2 ±9-9
o
o
o
o
o
o
o
o
89
44
5 5±3-8
Group 1: no clinical evidence of cardiac disease; Group 2: with clinical evidence of cardiac
disease; Group 3: diabetes mellitus type 1.
transplantation in Basel. Patients were eligible if
they developed irreversible renal failure below the
age of 66 years. Of these 113 patients, 98 received
a renal transplant between 1984 and 1987 (95
cadaveric grafts and three kidneys from living rela-
tive donors). All were treated after transplantation
with cyclosporine and low dose prednisone. Arhong
these 98 patients, only 10 received a kidney graft
without undergoing cardiac evaluation. In three
cases a matched graft was available before cardiac
examination, and in six the nephrologist in charge
decided not to do the exercise RNA in view of
the patients' young age (mean age of all 10
patients: 33 ±9 years). One patient refused cardiac
investigations.
Of the remaining 103 patients with cardiac
evaluation, 75 had no signs or symptoms of cardiac
disease (group 1), 19 had a history suggestive of
cardiac disease (group 2) and nine suffered from
diabetes mellitus type 1 (group 3). Table 1 shows
the baseline characteristics of the patients in these
three groups. Diabetic patients were younger than
group 2 patients. Toxic interstitial nephritis was the
leading cause of renal failure in both group 1 and 2.
Almost all patients in group 1 and 2 were on haemo-
dialysis, whereas five of nine diabetics were not on
haemodialysis.
Methods
CARDIAC INVESTIGATION
All patients underwent a thorough clinical assess-
ment that included history, physical examination,
chest X-ray and a 12-lead electrocardiogram
(ECG). The Minnesota criteria for CAD were
applied in the interpretation of the resting ECG151.
Patients without clinical evidence of cardiac disease
(group 1) were studied by exercise RNA. If left ven-
tricular ejection fraction (LVEF) at rest was below
40% and/or LVEF decreased ^ 5 % from rest to
symptom-limited exercise and regional left ven-
tricular wall motion abnormalities were observed,
coronary angiography was performed.
Patients with a history of heart disease, signs of
heart failure or valvular disease at physical examin-
ation, signs of ischaemic heart disease in the resting
ECG or an important enlargement of the cardiac
silhouette on chest X-ray were studied by angio-
graphy prior to kidney transplantation (group
2). All patients with insulin-dependent diabetes
mellitus (group 3) were investigated by coronary
angiography only.
EXERCISE RADIONUCLIDE ANGIOCARDIOGRAPHY
Radionuclide data were accumulated at rest and
continuously during exercise for LVEF determi-
nation, as previously described'61. Multiple gated
equilibrium radionuclide angiograms were per-
formed by in vivo labelling of red blood cells with
20 mCi technetium-99m after cold pyrophosphate
had been injected 20-30 min earlier. Imaging was
then recorded with a single crystal scintillation
camera of the Anger-type equipped with a high sen-
sitivity collimator in a 40c-50° left anterior oblique
and 5°-10° caudal tilt projection which best allowed
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separation of the left ventricle from other heart
chambers. Data acquisition was accomplished with
a commercially available nuclear medicine com-
puter system (Medtronic/MDS-A2 system). The
cardiac cycles of a 2 min acquisition period at rest
or peak exercise were assembled at corresponding
times to generate composite images throughout the
heart cycle and to calculate LVEF. Ejection frac-
tion was determined as previously reported; values
calculated by this technique have been shown to
correlate well with those determined from biplane
cineangiography'71. Regional wall motion was
visually assessed in five sectors of the left ventricle.
All patients underwent supine bicycle exercise
on an electronically braked Elema-Schonander
ergometer (type EM 350). The initial workload was
25 W. The load was increased in steps of 25 W until
appearance of symptoms: marked dyspnoea and/or
pain and fatigue in the legs and/or angina pectoris.
ECG and blood pressure were monitored during
the exercise test. The ECG was visually analysed
and the criteria for myocardial ischaemia were
applied as described by Fortuin and Weiss'81. Leads
with ST abnormalities at rest were not analysed. On
the day of exercise RNA, the patients were on their
usual medication including, in some, (3-blockers
and calcium-antagonists. No effort was made to
observe the same delay between the exercise RNA
and the last haemodialysis in all patients.
LEFT HEART CATHETERIZATION
Coronary angiography was performed using
standard Judkins technique (femoral artery punc-
ture). Right and left coronary artery were filmed in
three to four projections and visually assessed.
Obstruction in lumen diameter of >50% was
considered significant for CAD. Biplane contrast
ventriculography was done routinely and left
ventricular end-systolic volume, left ventricular
end-diastolic volume and LVEF were calculated
on a Philips semi-automatic Grafomed computer
system191.
FOLLOW-UP
Follow-up was based on medical records of the
nephrology out-patient service and on autopsy
reports. CAD was diagnosed if autopsy revealed
CAD as the cause of death or if two of the three
following criteria for myocardial infarction were
present: ECG changes typical for myocardial
infarction; ischaemic pain lasting > 30 min; tran-
sient elevation of creatine phosphokinase. Angina
pectoris and dyspnoea were not included as
end-points into follow-up.
STATISTICS
Data are given as mean± 1 standard deviation.
Comparisons between groups were performed
using Student's Mest for unpaired comparisons and
chi-square tests where appropriate. P values of
<005 were considered significant.
Results
PATIENTS WITHOUT A HISTORY OF CAD
Seventy-five patients with renal failure but no
clinical symptoms or signs of cardiac disease were
examined by exercise RNA (group 1). In 63 (84%)
LVEF at rest was ^40% and did not fall more than
5% during exercise; no regional wall motion abnor-
malities were found (group la, see Table 2). In this
group, maximally tolerated workload on supine
exercise was 53± 12 W at a heart rate of 111 ±18
beats min"1. Average LVEF at rest was 62 ± 10%,
and at maximal exercise 66 ± 10%. Four patients
showed a significant ST-depression on ECG with
no definite signs of ischaemia on RNA.
Sixty of 63 patients from group la received a
kidney transplant 10 ±7 months after the exercise
radionuclide study. These 60 patients were fol-
lowed-up for a period of 28 ± 7 months after cardiac
evaluation and of 19 ±9 months after transplan-
tation (Table 3). No patient in this group developed
signs or symptoms of CAD on clinical grounds. One
woman aged 60 years at the time of the exercise test
later presented with new Q waves in V1-V3 on the
ECG. Her radionuclide study had shown general
hypokinesia of the right ventricle. Echocardio-
graphic evidence for regional akinesia was not
found. The ECG changes in this patient reflected
cor pulmonale due to chronic obstructive lung
disease. In 49 patients the function of the kid-
ney graft was well preserved. Nine were back on
dialysis again and two patients had died (one
from septicaemia of unknown origin, one from
pneumonia).
In 12 of 75 patients (16%) the radionuclide
angiogram showed LVEF at rest < 40% and/or a
fall in LVEF during exercise of > 5% with or with-
out regional wall motion abnormalities (group lb,
see Table 2). In comparison with group 1 a, maximal
workload, exercise heart rate and LVEF at rest as
well as age did not differ. But this group of patients
showed, instead of an increase, a significant fall
in LVEF during exercise ( - 5 ± 5 % vs + 4 ± 6 %
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Table-2 Exercise RNA in 75 candidates for kidney transplantation without clinical evidence of
cardiac disease
Number of patients (n)
Women (%)
Age (years)
Maximal workload (W)
Exercise heart rate (beats min~')
ECG: ST-depression > 1 mm (n)
LVEF at rest (%)
LVEF during exercise (%)
Change in LVEF from rest to exercise (%)
Coronary angiograms performed (n)
one- or two-vessel CAD
hypertensive heart disease
Group la
63
59
52±I0
53±12
1I1±18
4
62 ±10
66±10
+4±6
Group lb
12
83
56±10
51 ±9
112±19
2
58 ±10*
53±9**
-5±5**
9
4
5
* = not significant, paired two-tailed (-test, group la vs lb; ** = / " < 0 0 1 , paired two-tailed
Mest, group la vs lb.
Abbreviations RNA = radionuclide angiocardiography; CAD = coronary artery disease;
LVEF = left ventricular ejection fraction.
Group la: no signs of CAD; Group lb: signs of CAD present (LVEF <40%, decrease of
LVEF during exercise of ? 5% and regional wall motion abnormalities).
Table 3 Follow-up in 88 patients after kidney transplantation
Group
Number of patients (n)
Follow-up after
cardiac evaluation (months)
kidney transplantation (months)
Graft function well preserved (n)
On haemodialysis at follow-up (n)
Death from cardiac disease (n)
Death from other cause (n)
la
60
28±7
19±9
49
9
0
2
lb
10
28±9
15±9
8
1
0
1
2
13
26±10
17±9
8
1
3
1
3
5
27±6
21 ±9
5
0
0
0
LVEF; P < 0 0 1 , Table 2). Only two patients
presented with significant ST-depression during
exercise in this group. Coronary angiography was
performed in nine of the 12 patients: one- or two-
vessel CAD was found in four patients (7% of the
total group 1). The risk of myocardial infarction
was considered low in these four subjects and
coronary artery bypass grafting or percutaneous
transluminal coronary angioplasty not recom-
mended. Five patients showed hypertensive heart
disease defined as LVEF < 40% at rest and/or a fall
in LVEF of more than 5% during exercise without
regional wall motion abnormalities but with left
ventricular hypertrophy without CAD at contrast
angiography and with a history of high blood
pressure treated with more than one antihyperten-
sive drug for more than 1 year. Angiography was
not performed in three patients: one received a
kidney transplant before the planned angiographic
procedure, one patient died of myocardial infarc-
tion before angiography at the age of 65 years, and
another was later denied kidney transplantation for
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other reasons. Ten out of 12 patients received a
kidney transplant; 15 + 9 months after transplan-
tation the grafts were functioning well in 8 subjects,
one patient was on dialysis again (Table 3). None
developed myocardial infarction. A 44-year-old
man died from cytomegalovirus infection after
kidney transplantation.
PATIENTS WITH CLINICAL SIGNS OF CAD
Nineteen patients with signs or symptoms of
cardiac disease were included in group 2 (Table 1).
Coronary angiography was performed in 18 and
showed one- to three-vessel disease in 14, hyperten-
sive heart disease in three and valvular heart disease
in one patient. Two patients underwent coronary
artery bypass surgery prior to transplantation. In
two patients coronary surgery and kidney trans-
plantation was not recommended due to extensive
CAD during the observation period. Thirteen of the
19 patients received a kidney graft; three of them
died after transplantation from CAD, one despite
coronary artery bypass surgery. At follow-up after
17±9 months the kidney grafts were functioning
well in eight subjects; one patient had to undergo
nephrectomy and was on dialysis again.
PATIENTS WITH JUVENILE DIABETES
Nine patients with juvenile diabetes mellitus were
in group 3 (Table 1). Coronary angiography was
performed in eight and CAD documented in two
patients. Coronary artery bypass surgery was not
recommended as the coronary disease was not
severe. Five of the nine patients including those two
with CAD have since received a kidney transplant
which showed satisfactory function at a follow-up
of 21 ± 9 months. Three patients died before kidney
transplantation (none from CAD) and one was
refused as a candidate for transplantation due to
general illness.
The overall incidence of CAD in candidates for
kidney transplantation examined either by RNA or
coronary angiography was therefore 20% (20/101).
The incidence did not differ between non-diabetic
and diabetic patients (20% vs 25%).
Discussion
We report the results of a systematic prospective
cardiac evaluation of 103 candidates for kidney
transplantation by exercise RNA and/or coronary
angiography and their follow-up over 19 months
after kidney transplantation. CAD is a major cause
of death in patients treated with kidney transplan-
tation'41. Our primary interest was to study those
candidates for kidney transplantation who showed
no clinical signs or symptoms of heart disease. We
assumed that detection of clinically occult CAD
would allow us to institute medical and/or surgical
therapy at an early stage of the disease and thereby
lower the incidence of myocardial infarction and
cardiac death.
DETECTION OF CAD IN PATIENTS WITH RENAL FAILURE
Coronary angiography would most accurately
identify patients at risk of CAD, but this expensive
examination, which is not without hazard, should
not be used in a population with relatively low
disease prevalence. On the other hand, the exercise
ECG alone is not very helpful in this patient group,
as confirmed by our findings: only 2 of 12 patients
without clinical evidence of CAD but radionuclide
signs of exercise-induced ischaemia showed clear-
cut ST-segment depression during exercise. This
low diagnostic accuracy of the exercise ECG is
partly due to the limited physical work capacity of
uraemic subjects. In addition, the exercise ECG is
difficult to interpret in patients with ST-T wave
changes already at rest as in patients with hyperten-
sive heart disease. Therefore, only horizontal or
downsloping ST-depression of > 1 mm in leads
with a normal ST-segment at rest was accepted as
diagnostic for myocardial ischaemia in this study.
Furthermore, thallium-201 stress testing has been
found to be no more predictive of future coronary
events than history and exercise ECG in uraemic
diabetics'l0). Exercise RNA has a sensitivity of
at least 90% and a specificity of around 80%
in patients with chest pain and normal kidney
function, when compared with coronary angio-
graphy'6'7', but the high prevalence of arterial
hypertension and hypertensive heart disease in
patients with end-stage renal disease results in lower
specificity if the usual criteria for normal exercise
RNA are applied (resting LVEF>50%, increase
from resting to exercise LVEF > 5% and absence of
regional left ventricular wall motion abnormali-
ties). Wassermann et al. showed that the increase in
LVEF from rest to exercise was below 5% in most
hypertensive patients with chest pain in whom
CAD could be excluded by angiography11".
Therefore, we diagnosed significant myocardial
ischaemia in patients with renal failure only if a
decrease in LVEF from rest to exercise of at least
5% in the presence of regional wall motion abnor-
malities was found. Further invasive investigation
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was also considered mandatory if resting LVEF was
<40%. This would not only identify patients with
CAD but also, hopefully, all those with significant
heart disease of other causes justifying invasive
examination.
SENSITIVITY AND SPECIFICITY OF EXERCISE RNA IN
URAEMIC PATIENTS WITHOUT SYMPTOMS OF HEART
DISEASE
Since the majority of the 75 subjects without
manifest heart disease (group 1) of our trial were
not studied by angiography, the sensitivity of
exercise RNA for CAD in patients with end-stage
kidney disease cannot be determined. It is of note,
however, that over a follow-up period of 28 ± 7
months after the radionuclide study or 19 months
after kidney transplantation, none of the 60 patients
without ischaemia during exercise RNA developed
CAD based on clinical information. Therefore, sig-
nificant CAD is very unlikely to develop over the
following 2-3 years in uraemic patients with a
negative radionuclide exercise text. Exercise RNA,
therefore, successfully identified patients at low risk
of cardiac complications.
On the other hand, 16% of uraemic patients
without signs or symptoms of heart disease showed
severe resting or exercise-induced left ventricular
dysfunction in the radionuclide study as defined
above. In half of them one- or two-vessel CAD was
detected, in the other half left ventricular dys-
function could be explained by hypertensive heart
disease. Blood pressure during exercise was of no
value in differentiating these two subgroups. Thus,
the sensitivity of exercise RNA for CAD was only
50%; the sensitivity for CAD or severe hypertensive
heart disease, however, was excellent.
PATIENTS WITH RENAL FAILURE AND DOCUMENTED
CAD
In contrast to expectations, this protocol did not
identify patients with clinically occult high-grade
coronary stenoses, who would undoubtedly benefit
from coronary artery bypass surgery or angio-
plasty. We based the selection of uraemic patients
for surgery or angioplasty on the usual criteria
derived from the CASS study and the European
Trial on Coronary Surgery'12'131. However, the
number of patients was too small to allow definite
conclusions. Over a follow-up of 15 ±7 months
after kidney transplantation, the four patients with
a one- or two-vessel CAD developed no clinical
signs of CAD after transplantation. Repeated RNA
in these patients will hopefully allow early
detection of an increase in coronary stenoses and
prevention of myocardial infarction by surgery or
angioplasty.
Eighteen patients with clinically apparent cardiac
disease were studied by coronary angiography. The
angiographic findings were useful for the identifi-
cation of patients with severe CAD and a limited
prognosis who had to be excluded from kidney
transplantation for this reason. On the other hand,
the high mortality rate from CAD after kidney
grafting in this group (3/13, 23%) raises the ques-
tion of the management of patients after kidney
transplantation with known CAD. As reported
by several authors, surgery is feasible in uraemic
patients but at an increased risk'141 and symptomatic
CAD can also successfully be treated with balloon
angioplasty in these patients'15"181. However, we
still lack a larger controlled trial to answer the
question whether interventions such as angioplasty
or coronary surgery should be performed more
aggressively in patients with known of CAD after
kidney transplantation'"'201.
CAD IN RENAL FAILURE DUE TO JUVENILE DIABETES
Eight patients with diabetic kidney failure with-
out clinically apparent heart disease were studied by
coronary angiography. CAD was found only in two
patients, comparable to the incidence of CAD in
non-diabetic patients with renal failure (20%).
This is in accordance with a report of Braun et al.,
who observed a prevalence of 21% of CAD in 100
diabetic patients with chronic renal failure'2'1.
Conclusions and implications
This study confirms the high incidence of CAD of
20% to 25% in patients with chronic renal failure
who are candidates for kidney transplantation.
According to the reported observation, this inci-
dence was similar for diabetic and non-diabetic
patients. In asymptomatic patients, scintigraphic
cardiac evaluation using rest and exercise radio-
nuclide angiocardiography had a high prognostic
accuracy to exclude CAD: no patient developed
clinical signs or symptoms of CAD during a mean
follow-up of 28 months. On the other hand, patients
with an abnormal scintigraphic result as denned for
this study all had either CAD or hypertensive left
ventricular dysfunction.
Thus, in patients with renal failure and no signs
or symptoms of heart disease, clinical examination
combined with exercise RNA had a high diagnostic
accuracy to predict absence of late manifestations
838 C. Cottier et al.
of CAD. However, patients with non-invasively
detected asymptomatic CAD had no cardiac events
during the observation period of this study; it
remains to be shown by future studies, therefore,
whether the treatment of silent ischaemia will
improve long-term prognosis. If it can be demon-
strated prospectively that medical or interventional
treatment of early, clinically silent CAD is bene-
ficial as suggested in a retrospective analysis1221, then
a screening strategy as proposed in this study will
provide important information.
We would like to thank Cathy Faes for her secretarial
assistance.
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